Pharmacology of glucocorticoids;Pharmacologie des glucocorticoïdes

Presse Medicale

Volumn 41, Issue 4, 2012, Pages 370-377

  Le Jeunne, Claire ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; NEW DRUG;

ADVERSE OUTCOME; ASTHMA; DRUG LABELING; DRUG MARKETING; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; GENETIC TRANSCRIPTION; HUMAN; PRESCRIPTION; RISK BENEFIT ANALYSIS; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; TREATMENT INDICATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG DESIGN; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RISK ASSESSMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84858751808     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.01.007     Document Type: Short Survey

References (24)

1. Young F.G. Thomas Addison and the background to cortisone. Br Med J 1951, 2(4747):1535-1541.
2. Bringer J., Lefebvre P. La corticothérapie en pratique. Brion, Guillevin, Le Parc 1998, Masson, Paris, p. 3-7.
3. Chast F. Histoire contemporaine des médicaments 1995, La découverte, Paris, p. 384.
4. Françon F. In memoriam. Philip Showalter Hench (1896-1965) and the épopée of cortisone. Rhumatologie 1966, 18(1):35-37.
5. Homburger F., Bonner C.D. The treatment of Raoul Dufy's arthritis. N Eng J Med 1979, 301:669-673.
6. Van der Laan S., Meijer O.C. Pharmacology of glucocorticoids: beyond receptors. Eur J Pharmacol 2008, 585:483-491.
7. Goodman, Gilman's The pharmacological basis of therapeutics 2006, Mc Graw-Hill companies, New York, p. 1593-610. 11th ed.
8. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 2005, 353:1711-1723.
9. Lowenberg M., Stahn C., Hommes D., Buttgereit F Novel insights into mechanisms of glucocorticoid action and development of new glucocorticoid receptor ligands. Steroids 2008, 73:1025-1029.
10. De Bosscher K., Haegemean G., Elewaut D. Targeting inflammation using selective glucocorticoid receptor modulators. Curr Opin Pharmacol 2010, 10:497-504.
11. Buttgereit F., Scheffold A. Rapid glucocorticoids effects on immune cells. Steroids 2002, 67:529-534.
12. Barnes P.J. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011, 163:29-43.
13. Czok D., Keller F., Rashe F., Haussler U. Pharmacokinetics and pharmacodynamics of systematically administered glucocorticosteroids. Clin Pharmacokinet 2005, 44:61-98.
14. Benediktsson R., Calder A.A., Edwards C.R.W., Sekl J.R. Placental 11b hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol 1997, 46:161-166.
15. Brownfoot FC, Crowther CA, Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2008;4 [Review].
16. Waldman S., Terzic A. Pharmacology and therapeutics principles to practice 2009, Ed Saunders, Philadelphia. 1st ed.
17. Moghadam-Kia S., Werth V.P. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol 2010, 49:239-248.
18. Schacke H., Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticostroids. Pharmacol Ther 2002, 96:23-43.
19. Goichot B., Vinzio S., Luca F., Schlienger J.L. Que reste-t-il de l'insuffisance surrénale post-corticothérapie ?. Presse Med 2007, 36:1065-1071.
20. Buttgereit F., Doering G., Schaeffler A., Witte S., Sierakowski S., et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis 2009, 69:1275-1280.
21. Contopoulos-Loannidis D.G., Loannidis J.P. Claims for improved survival from systemic corticosteroids in diverse conditions: an umbrella review. Cochrane Database Syst Rev 2011, 10:365-2362.
22. Snidvongs K., Kalish L., Sacks R., Craig J.C., Harvey R.J. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev 2011, 10:CD009274.
23. Basch E., Prestrud A.A., Hesketh P.J., Kris M.G., Feyer P.C., Somerfield M.R., et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2011, 29(31):4189-4198.
24. Chartapisak Purpura rheumatoid. Cochrane Database of Systematic Reviews 2009, Davin. cJASN 2011, 6:679.